Compare TARA & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARA | PKBK |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 314.7M |
| IPO Year | 2014 | 2005 |
| Metric | TARA | PKBK |
|---|---|---|
| Price | $5.11 | $28.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $21.67 | N/A |
| AVG Volume (30 Days) | ★ 673.0K | 64.7K |
| Earning Date | 05-07-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | 38.25 | ★ 39.21 |
| EPS | N/A | ★ 3.16 |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $16.94 |
| 52 Week High | $7.82 | $29.50 |
| Indicator | TARA | PKBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 56.99 |
| Support Level | $4.95 | $26.56 |
| Resistance Level | $5.39 | $29.28 |
| Average True Range (ATR) | 0.29 | 0.60 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 44.93 | 66.67 |
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.